Skip to main content
Clinical Trials/NCT04870385
NCT04870385
Unknown
N/A

An Islamic Psychospiritual-Acceptance and Commitment-based Prevention Program for At-Risk Young Adults in the COVID-19 Pandemic

International Islamic University Malaysia1 site in 1 country120 target enrollmentApril 11, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psychological Distress
Sponsor
International Islamic University Malaysia
Enrollment
120
Locations
1
Primary Endpoint
Changes in psychological distress
Last Updated
4 years ago

Overview

Brief Summary

The COVID-19 pandemic has increased mental health concerns worldwide, and young adults are at higher risk of experiencing increased psychological distress due to the pandemic. University students face compounding stressors during the pandemic, such as online and remote learning, economic insecurity, and uncertain career prospects. This study aims to evaluate the effectiveness of an online modular prevention program featuring integrated elements of Acceptance and Commitment Therapy (ACT) and Islamic spirituality in reducing the psychological distress and increasing the psychological flexibility, self-compassion, and resilience of Muslim university students in Malaysia.

Registry
clinicaltrials.gov
Start Date
April 11, 2021
End Date
August 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jamilah Hanum Abdul Khaiyom, PhD

Assistant Professor

International Islamic University Malaysia

Eligibility Criteria

Inclusion Criteria

  • Undergraduate or postgraduate student enrolled in a Malaysian university
  • aged 18-29 years old
  • Obtained moderate and above levels in either one of the stress, anxiety, and depression subscales of the DASS-21 pre-intervention assessment
  • Owns a gadget with Internet access
  • Can read and understand English

Exclusion Criteria

  • Those with previous experience with a modular ACT-based treatment with Islamic elements
  • Those with past or present diagnosis of mental/neurological disorder
  • Those reporting active suicidality
  • Those involved in any other form of psychological treatment (ie. psychotherapy, pharmacotherapy)

Outcomes

Primary Outcomes

Changes in psychological distress

Time Frame: Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up

Measured using the Depression, Anxiety, and Stress Scale (DASS-21; Lovibond \& Lovibond, 1995).

Secondary Outcomes

  • Changes in psychological flexibility(Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up)
  • Changes in self-compassion.(Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up)
  • Changes in resilience(Measured at pre-intervention, mid-intervention (third week of prevention program), post-intervention (up to 1-week after completion of program), and 1-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials